Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-May-24 10:00 PM View:  | Phathom Pharmaceuticals, Inc. (PHAT) | 23-May-24 | Grant | 10,500 | -- | -- | < 1% 1.22M to 1.23M | |
| 30-May-23 6:57 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | < 1% 1.21M to 1.22M | |
| 08-Oct-21 6:28 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 08-Oct-21 | Market Sale | 2,529 | $32.05 | $81,051.90 | (< 1%) 1.21M to 1.21M | (2%) |
| 08-Oct-21 6:28 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 07-Oct-21 | Market Sale (Planned) | 15,471 | $32.66 | $505,343.00 | (1%) 1.23M to 1.21M | (< 1%) |
| 23-Sep-21 10:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Sep-21 | Market Sale | 4,100 | $32.06 | $131,446.00 | (< 1%) 1.23M to 1.23M | < 1% |
| 23-Sep-21 10:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 21-Sep-21 | Market Sale | 324 | $33.31 | $10,791.10 | (< 1%) 1.25M to 1.25M | 4% |
| 23-Sep-21 10:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 21-Sep-21 | Market Sale (Planned) | 13,576 | $32.79 | $445,114.00 | (1%) 1.25M to 1.23M | 3% |
| 29-Jun-21 8:43 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 29-Jun-21 | Market Sale | 13,960 | $34.00 | $474,657.00 | (1%) 1.28M to 1.26M | (1%) |
| 29-Jun-21 8:43 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 28-Jun-21 | Market Sale | 156 | $35.09 | $5,473.56 | (< 1%) 1.3M to 1.3M | 2% |
| 29-Jun-21 8:43 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 28-Jun-21 | Market Sale (Planned) | 25,884 | $34.07 | $881,811.00 | (2%) 1.3M to 1.28M | (1%) |
| 21-May-21 6:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 20-May-21 | Market Sale | 3,482 | $34.66 | $120,687.00 | (< 1%) 1.3M to 1.3M | (2%) |
| 21-May-21 6:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-May-21 | Market Sale | 19,249 | $32.88 | $632,976.00 | (1%) 1.34M to 1.32M | (7%) |
| 21-May-21 6:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-May-21 | Market Sale (Planned) | 17,269 | $31.96 | $551,843.00 | (1%) 1.32M to 1.3M | (10%) |
| 07-Apr-21 4:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 06-Apr-21 | Market Sale | 17,882 | $37.17 | $664,684.00 | (1%) 1.36M to 1.34M | (3%) |
| 07-Apr-21 4:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 05-Apr-21 | Market Sale | 9,499 | $36.54 | $347,068.00 | (< 1%) 1.38M to 1.37M | (4%) |
| 07-Apr-21 4:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 05-Apr-21 | Market Sale (Planned) | 12,619 | $35.69 | $450,337.00 | (< 1%) 1.37M to 1.36M | (7%) |
| 12-Mar-21 5:54 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 12-Mar-21 | Market Sale | 500 | $46.67 | $23,335.00 | (< 1%) 1.38M to 1.38M | (2%) |
| 12-Mar-21 5:54 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 11-Mar-21 | Market Sale | 42,429 | $47.19 | $2,002,100.00 | (3%) 1.42M to 1.38M | (< 1%) |
| 12-Mar-21 5:54 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 10-Mar-21 | Market Sale | 9,646 | $49.19 | $474,490.00 | (< 1%) 1.44M to 1.43M | 3% |
| 12-Mar-21 5:54 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 10-Mar-21 | Market Sale (Planned) | 2,425 | $48.32 | $117,167.00 | (< 1%) 1.43M to 1.42M | 2% |
| 23-Feb-21 6:14 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 23-Feb-21 | Market Sale | 4,984 | $43.74 | $217,991.00 | (< 1%) 1.44M to 1.44M | (5%) |
| 23-Feb-21 6:14 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Feb-21 | Market Sale | 20,140 | $45.66 | $919,587.00 | (1%) 1.46M to 1.44M | (< 1%) |
| 23-Feb-21 6:14 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Feb-21 | Market Sale | 39,676 | $47.33 | $1,877,730.00 | (3%) 1.51M to 1.47M | 3% |
| 23-Feb-21 6:14 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Feb-21 | Market Sale (Planned) | 5,200 | $46.02 | $239,308.00 | (< 1%) 1.47M to 1.46M | < 1% |
| 13-Jan-21 5:07 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 12-Jan-21 | Market Sale | 27,165 | $36.07 | $979,795.00 | (2%) 1.56M to 1.53M | (< 1%) |
| 13-Jan-21 5:07 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 11-Jan-21 | Market Sale (Planned) | 12,835 | $34.92 | $448,243.00 | (< 1%) 1.57M to 1.56M | (4%) |
| 18-Dec-20 8:01 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 17-Dec-20 | Sale | 48,212 | $40.74 | $1,964,380.00 | (3%) 1.62M to 1.57M | |
| 18-Dec-20 8:01 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 16-Dec-20 | Sale | 26,446 | $47.77 | $1,263,420.00 | (2%) 1.65M to 1.63M | |
| 18-Dec-20 8:01 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 16-Dec-20 | Sale (Planned) | 5,000 | $46.22 | $231,102.00 | (< 1%) 1.63M to 1.62M | |
| 12-Feb-21 10:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Dec-20 | Gift | 27,000 | -- | -- | (2%) 1.53M to 1.51M | |
| 12-Nov-20 4:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 11-Nov-20 | Sale | 6,877 | $38.97 | $268,021.00 | (< 1%) 1.66M to 1.65M | |
| 12-Nov-20 4:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 10-Nov-20 | Sale | 12,681 | $41.69 | $528,672.00 | (< 1%) 1.67M to 1.66M | |
| 12-Nov-20 4:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 09-Nov-20 | Sale | 5,577 | $42.69 | $238,083.00 | (< 1%) 1.69M to 1.68M | |
| 12-Nov-20 4:13 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 09-Nov-20 | Sale (Planned) | 5,207 | $41.95 | $218,422.00 | (< 1%) 1.68M to 1.68M | |
| 15-Jun-10 5:07 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Jun-10 | Market Sale (Planned) | 10,000 | $7.05 | $70,500.00 | (9%) 106.25K to 96.25K | (12%) |
| 11-May-10 4:43 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 10-May-10 | Market Sale (Planned) | 10,000 | $9.20 | $92,014.00 | (9%) 116.25K to 106.25K | 14% |
| 20-Apr-10 5:50 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Apr-10 | Market Sale (Planned) | 5,000 | $10.00 | $50,000.00 | (4%) 121.25K to 116.25K | 21% |
| 13-Apr-10 4:28 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Apr-10 | Market Sale (Planned) | 10,000 | $9.31 | $93,076.00 | (8%) 131.25K to 121.25K | 15% |
| 09-Mar-10 4:34 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Mar-10 | Market Sale (Planned) | 10,000 | $9.30 | $92,973.00 | (7%) 141.25K to 131.25K | 15% |
| 09-Feb-10 7:05 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Feb-10 | Market Sale (Planned) | 12,500 | $10.26 | $128,190.00 | (8%) 153.75K to 141.25K | 23% |
| 12-Jan-10 6:05 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 11-Jan-10 | Market Sale (Planned) | 12,500 | $10.06 | $125,752.00 | (8%) 166.25K to 153.75K | 22% |
| 04-Jan-10 4:12 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 04-Jan-10 | Option Exercise | 25,000 | $0.40 | $10,000.00 | 18% 141.25K to 166.25K | |
| 18-Dec-09 5:59 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 17-Dec-09 | Market Sale (Planned) | 2,500 | $10.00 | $25,000.00 | (2%) 143.75K to 141.25K | 21% |
| 16-Dec-09 4:09 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Dec-09 | Market Sale (Planned) | 10,000 | $9.34 | $93,427.00 | (7%) 153.75K to 143.75K | 16% |
| 10-Nov-09 7:29 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 09-Nov-09 | Market Sale (Planned) | 12,500 | $10.00 | $125,055.00 | (8%) 166.25K to 153.75K | 21% |
| 13-Oct-09 5:39 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Oct-09 | Market Sale (Planned) | 12,500 | $11.60 | $145,032.00 | (7%) 178.75K to 166.25K | 32% |
| 15-Sep-09 9:05 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Sep-09 | Market Sale (Planned) | 12,500 | $10.69 | $133,610.00 | (7%) 191.25K to 178.75K | 26% |
| 12-Aug-09 4:52 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 10-Aug-09 | Market Sale (Planned) | 12,500 | $10.98 | $137,278.00 | (6%) 203.75K to 191.25K | 28% |
| 15-Jul-09 4:32 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 13-Jul-09 | Market Sale (Planned) | 12,500 | $10.33 | $129,115.00 | (6%) 216.25K to 203.75K | 27% |
| 22-Feb-08 5:25 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Feb-08 | Grant | 3,745 | $5.34 | $19,998.30 | 2% 212.5K to 216.25K | 39% |